His main research concerns Surgery, Hepatectomy, Internal medicine, Gastroenterology and Cancer. The study incorporates disciplines such as Colorectal cancer and Metastasis in addition to Surgery. His Hepatectomy research incorporates elements of Hepatocellular carcinoma, Survival analysis, Radiology and Intrahepatic Cholangiocarcinoma.
Adenocarcinoma and Clinical trial is closely connected to Oncology in his research, which is encompassed under the umbrella topic of Internal medicine. The various areas that William R. Jarnagin examines in his Gastroenterology study include Disease, Pathology and Hepatic arterial infusion. His Cancer research integrates issues from Carcinoma, Incidence and Gallbladder.
His primary areas of investigation include Surgery, Internal medicine, Hepatectomy, Gastroenterology and Radiology. Surgery is closely attributed to Metastasis in his work. William R. Jarnagin regularly ties together related areas like Oncology in his Internal medicine studies.
His Hepatectomy research is multidisciplinary, incorporating elements of Proportional hazards model and Survival analysis. His study in the fields of Intrahepatic Cholangiocarcinoma under the domain of Gastroenterology overlaps with other disciplines such as In patient. He combines subjects such as Hepatocellular carcinoma, Malignancy and Pancreas with his study of Radiology.
The scientist’s investigation covers issues in Internal medicine, Gastroenterology, Chemotherapy, Surgery and Radiology. His work on Hazard ratio, Colorectal cancer and Cancer as part of general Internal medicine study is frequently connected to In patient, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. His work carried out in the field of Cancer brings together such families of science as Cancer research and Pancreas.
His Gastroenterology study incorporates themes from KRAS, Hepatectomy, Cumulative incidence and Retrospective cohort study. William R. Jarnagin has researched Chemotherapy in several fields, including Artery infusion, Adjuvant, Metastasis, Hepatic arterial infusion and Disease. His Ultrasound, Image guidance and Radiomics study in the realm of Radiology interacts with subjects such as Occult.
His main research concerns Internal medicine, Oncology, Cancer, Cohort and Retrospective cohort study. William R. Jarnagin has included themes like Gastroenterology and Hepatectomy in his Internal medicine study. His Cancer study deals with Proportional hazards model intersecting with Radiology.
The study incorporates disciplines such as Surgical oncology and Colorectal cancer in addition to Survival rate. Clinical endpoint is a subfield of Surgery that William R. Jarnagin investigates. His work often combines Surgery and Validation study studies.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Tumour exosome integrins determine organotropic metastasis
Ayuko Hoshino;Bruno Costa-Silva;Tang-Long Shen;Goncalo Rodrigues.
Nature (2015)
Improvement in Perioperative Outcome After Hepatic Resection: Analysis of 1,803 Consecutive Cases Over the Past Decade
William R. Jarnagin;Mithat Gonen;Yuman Fong;Ronald P. DeMatteo.
Annals of Surgery (2002)
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
Bruno Costa-Silva;Nicole M. Aiello;Allyson J. Ocean;Swarnima Singh.
Nature Cell Biology (2015)
Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.
William R. Jarnagin;Yuman Fong;Ronald P. DeMatteo;Mithat Gonen.
Annals of Surgery (2001)
Actual 10-Year Survival After Resection of Colorectal Liver Metastases Defines Cure
James S. Tomlinson;William R. Jarnagin;Ronald P. DeMatteo;Yuman Fong.
Journal of Clinical Oncology (2007)
Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka
Go Wakabayashi;Daniel Cherqui;David A. Geller;Joseph E. Buell.
Annals of Surgery (2015)
An analysis of 412 cases of hepatocellular carcinoma at a Western center.
Yuman Fong;Ruth L. Sun;William Jarnagin;Leslie H. Blumgart.
Annals of Surgery (1999)
Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection.
Itaru Endo;Mithat Gonen;Adam C. Yopp;Kimberly M. Dalal.
Annals of Surgery (2008)
Influence of Transfusions on Perioperative and Long-Term Outcome in Patients Following Hepatic Resection for Colorectal Metastases
David A. Kooby;Jennifer Stockman;Leah Ben-Porat;Mithat Gonen.
Annals of Surgery (2003)
Hepatic neuroendocrine metastases: does intervention alter outcomes?
Ronald S Chamberlain;David Canes;Karen T Brown;Leonard Saltz.
Journal of The American College of Surgeons (2000)
Journal of the American College of Surgeons
(Impact Factor: 6.532)
HPB
(Impact Factor: 3.842)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Memorial Sloan Kettering Cancer Center
University of Pennsylvania
Duke University
City Of Hope National Medical Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Google (United States)
Technical University of Munich
Aarhus University
University of Alberta
ExxonMobil (United States)
University of Manchester
University of California, Davis
Smith College
Florida International University
National Health Laboratory Service
Federal University of Toulouse Midi-Pyrénées
Universidade de São Paulo
Icahn School of Medicine at Mount Sinai
Mayo Clinic
Kyoto University
Harvard University